Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05523349 · ClinicalTrials.gov registry record · NA
An Investigation on Function and Performance of a New Microprocessor Controlled Prosthetic Knee
A NA study, sponsored by Össur Iceland ehf.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT05523349: Completed NA study, sponsored by Össur Iceland ehf.
NCT05523349 is a NA study that has completed, run by Össur Iceland ehf. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05523349, a NA study, has completed, sponsored by Össur Iceland ehf.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This investigation aims to compare the functional performance of a new passive microprocessor-controlled Prosthetic Knee to subjects usual microprocessor-controlled prosthetic knee.
Primary Outcome
A question from the Prosthesis Evaluation Questionnaire (PEQ) regarding the satisfaction of walking downstairs is answered; scale allows for values from 1 to 10 while 1 represents very low satisfaction and 10 high satisfaction. The analysis was done by using a Bayesian approach which presents the posterior distribution of effects between Visit 2 and visit 3. The parameter for analysis is the difference of the score between Visits 2 and 3. If scores in Visit 2 (subjects using the investigational
Interventions
- DEVICE NAVii
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2022-08-15 |
| Est. Completion | 2022-09-30 |
| Phase | NA |
What the finished NCT05523349 record still lists
NCT05523349 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which NAVii is the first listed.
NCT05523349 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05523349 about?
NCT05523349 is a clinical study titled "An Investigation on Function and Performance of a New Microprocessor Controlled Prosthetic Knee". This investigation aims to compare the functional performance of a new passive microprocessor-controlled Prosthetic Knee to subjects usual microprocessor-controlled prosthetic knee.
What is the current status of trial NCT05523349?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2022-08-15. Estimated completion is 2022-09-30.
What interventions are being tested in trial NCT05523349?
The interventions under investigation include: NAVii (DEVICE).
Who is sponsoring clinical trial NCT05523349?
This trial is sponsored by Össur Iceland ehf, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05523349's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy